Anti-CD19 Chimeric Antigen Receptor Modified T Cells Infusion in Mantle Cell Lymphoma
Latest Information Update: 06 Nov 2021
At a glance
- Drugs Anti CD19 chimeric antigen receptor T cell therapy AbelZeta Pharma (Primary)
- Indications Mantle-cell lymphoma
- Focus Adverse reactions
Most Recent Events
- 27 Feb 2015 New trial record